Nifty
:
25299.35
Sensex
:
81911.01
44.30 (0.18%)
31.61 (0.04%)
Nifty
Sensex
:
:
25299.35
81911.01
44.30 (0.18%)
31.61 (0.04%)

Strides Pharma Science Ltd.

Pharmaceuticals & Drugs - Global

Rating :
66/99

BSE: 532531 | NSE: STAR

NSE BSE
1009.30
12-Nov-2026
  • Open
  • High
  • Low
  • Previous Close
  •  1001
  •  1017.5
  •  985.1
  •  999.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  381960
  •  383165384.1
  •  1260.9
  •  768.65

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 9,291.77
  • 15.06
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,991.41
  • 0.50%
  • 2.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 29.00%
  • 3.72%
  • 19.69%
  • FII
  • DII
  • Others
  • 27.98%
  • 13.87%
  • 5.74%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.84
  • 9.61
  • 7.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.82
  • 21.40
  • 8.10

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.07
  • 0.38
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.15
  • -
  • 16.43

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.34
  • 2.60
  • 3.36

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.31
  • 15.22
  • 11.57

Earnings Forecasts:

(Updated: 07-11-2026)
Description
2026
2027
2028
2029
Adj EPS
60.34
60.3
81.8
107.9
P/E Ratio
16.73
16.74
12.34
9.35
Revenue
4858.68
5701.4
6655.5
7643.1
EBITDA
925.29
1059.4
1296.8
1592.2
Net Income
556.19
556
753.8
994.2
ROA
8.57
-
-
-
P/B Ratio
2.99
2.51
2.05
-
ROE
19.66
16.4
19
20.9
FCFF
117.92
112
622.5
809.3
FCFF Yield
1.08
1.03
5.72
7.44
Net Debt
1544.84
1368.7
1068.7
868.7
BVPS
337.15
401.83
493.28
-

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 26
Sep 25
Var%
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Net Sales
1,429.73
1,220.83
17.11%
1,265.41
1,119.74
13.01%
1,323.47
1,190.39
11.18%
1,194.65
1,153.67
3.55%
Expenses
1,178.82
989.26
19.16%
1,035.63
901.66
14.86%
1,083.76
972.52
11.44%
958.70
943.35
1.63%
EBITDA
250.91
231.57
8.35%
229.77
218.07
5.37%
239.71
217.87
10.02%
235.94
210.31
12.19%
EBIDTM
17.55%
18.97%
18.16%
19.48%
18.11%
18.30%
19.75%
18.23%
Other Income
4.08
27.14
-84.97%
4.89
8.58
-43.01%
8.13
11.98
-32.14%
106.86
5.62
1,801.42%
Interest
46.54
46.13
0.89%
40.56
47.46
-14.54%
41.58
50.32
-17.37%
43.38
52.18
-16.86%
Depreciation
57.21
49.64
15.25%
56.40
48.89
15.36%
53.25
48.86
8.98%
50.62
48.42
4.54%
PBT
149.54
154.17
-3.00%
200.90
121.94
64.75%
146.60
103.25
41.99%
245.51
112.89
117.48%
Tax
16.32
21.59
-24.41%
34.12
16.45
107.42%
18.77
20.76
-9.59%
37.35
23.80
56.93%
PAT
133.22
132.57
0.49%
166.78
105.49
58.10%
127.83
82.49
54.96%
208.15
89.09
133.64%
PATM
9.32%
10.86%
13.18%
9.42%
9.66%
6.93%
17.42%
7.72%
EPS
14.19
13.84
2.53%
17.03
10.81
57.54%
13.77
8.92
54.37%
21.93
9.54
129.87%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
5,213.26
4,858.68
4,565.34
3,890.13
3,688.39
3,070.25
3,315.87
2,751.97
2,178.37
2,845.11
2,755.44
Net Sales Growth
11.28%
6.43%
17.36%
5.47%
20.13%
-7.41%
20.49%
26.33%
-23.43%
3.25%
 
Cost Of Goods Sold
2,123.80
1,958.72
1,979.96
1,749.05
1,626.88
1,502.32
1,332.79
1,122.48
1,085.20
1,378.84
1,281.17
Gross Profit
3,089.46
2,899.95
2,585.37
2,141.07
2,061.50
1,567.93
1,983.08
1,629.49
1,093.18
1,466.28
1,474.27
GP Margin
59.26%
59.69%
56.63%
55.04%
55.89%
51.07%
59.81%
59.21%
50.18%
51.54%
53.50%
Total Expenditure
4,256.91
4,014.13
3,767.56
3,317.89
3,303.09
3,091.76
2,689.06
2,236.07
1,936.06
2,442.83
2,228.09
Power & Fuel Cost
-
66.38
58.17
75.13
85.82
71.54
64.58
64.49
54.39
51.33
33.87
% Of Sales
-
1.37%
1.27%
1.93%
2.33%
2.33%
1.95%
2.34%
2.50%
1.80%
1.23%
Employee Cost
-
928.96
862.76
737.05
732.02
646.91
550.15
442.56
329.44
434.05
419.16
% Of Sales
-
19.12%
18.90%
18.95%
19.85%
21.07%
16.59%
16.08%
15.12%
15.26%
15.21%
Manufacturing Exp.
-
402.64
311.98
299.81
259.45
255.52
237.94
210.79
150.98
141.97
145.40
% Of Sales
-
8.29%
6.83%
7.71%
7.03%
8.32%
7.18%
7.66%
6.93%
4.99%
5.28%
General & Admin Exp.
-
251.45
221.56
198.06
232.21
223.67
191.73
191.89
150.10
194.38
172.63
% Of Sales
-
5.18%
4.85%
5.09%
6.30%
7.29%
5.78%
6.97%
6.89%
6.83%
6.27%
Selling & Distn. Exp.
-
357.11
298.20
215.03
263.65
331.30
223.22
137.07
111.22
208.85
161.12
% Of Sales
-
7.35%
6.53%
5.53%
7.15%
10.79%
6.73%
4.98%
5.11%
7.34%
5.85%
Miscellaneous Exp.
-
48.85
34.93
43.76
103.06
60.51
88.65
66.79
54.74
33.41
161.12
% Of Sales
-
1.01%
0.77%
1.12%
2.79%
1.97%
2.67%
2.43%
2.51%
1.17%
0.53%
EBITDA
956.33
844.55
797.78
572.24
385.30
-21.51
626.81
515.90
242.31
402.28
527.35
EBITDA Margin
18.34%
17.38%
17.47%
14.71%
10.45%
-0.70%
18.90%
18.75%
11.12%
14.14%
19.14%
Other Income
123.96
231.45
63.76
49.85
135.22
133.40
59.44
53.11
40.84
88.32
161.08
Interest
172.06
178.54
248.85
280.22
261.14
176.74
150.06
155.72
79.29
196.24
183.10
Depreciation
217.48
202.40
192.26
213.64
243.25
233.01
206.29
173.70
117.39
154.03
126.15
PBT
742.55
695.06
420.42
128.22
16.11
-297.88
329.90
239.59
86.47
140.32
379.18
Tax
106.56
94.17
77.52
29.11
-55.30
-178.26
31.65
11.32
-26.86
5.68
63.41
Tax Rate
14.35%
14.09%
15.98%
-47.86%
6010.87%
32.91%
8.48%
6.99%
-24.85%
5.87%
18.50%
PAT
635.98
556.19
405.34
-120.20
-221.20
-460.21
254.50
49.16
83.99
54.39
233.51
PAT before Minority Interest
615.77
574.52
409.40
-143.90
-230.90
-474.25
243.79
43.36
89.25
74.26
279.71
Minority Interest
-20.21
-18.33
-4.06
23.70
9.70
14.04
10.71
5.80
-5.26
-19.87
-46.20
PAT Margin
12.20%
11.45%
8.88%
-3.09%
-6.00%
-14.99%
7.68%
1.79%
3.86%
1.91%
8.47%
PAT Growth
55.25%
37.22%
-
-
-
-
417.70%
-41.47%
54.42%
-76.71%
 
EPS
68.98
60.32
43.96
-13.04
-23.99
-49.91
27.60
5.33
9.11
5.90
25.33

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
3,107.57
2,551.83
2,125.57
2,212.26
2,359.23
2,776.66
2,527.42
2,648.70
2,463.66
2,748.82
Share Capital
92.17
92.16
91.90
90.30
89.79
89.68
89.56
89.55
89.50
89.42
Total Reserves
3,014.84
2,459.16
2,030.57
2,102.54
2,266.99
2,682.26
2,432.13
2,551.59
2,365.10
2,650.55
Non-Current Liabilities
598.54
601.61
621.44
1,210.30
965.72
1,264.45
813.65
2,342.88
2,067.29
2,048.67
Secured Loans
536.45
558.62
618.40
1,040.81
744.86
873.43
601.79
1,806.45
1,551.09
1,622.87
Unsecured Loans
15.87
12.62
53.10
98.98
90.77
9.15
2.12
0.06
0.23
14.84
Long Term Provisions
126.36
113.94
91.63
73.42
64.28
246.50
63.95
52.24
16.55
25.19
Current Liabilities
2,895.49
2,591.52
2,879.26
2,990.20
3,411.68
2,738.35
2,544.86
2,662.24
1,896.17
3,103.87
Trade Payables
1,309.68
1,032.50
851.59
982.34
1,071.52
1,134.20
797.75
888.99
712.07
774.09
Other Current Liabilities
401.72
307.41
341.57
527.89
697.18
421.00
354.49
248.12
126.85
819.08
Short Term Borrowings
1,039.34
1,136.36
1,574.15
1,330.76
1,496.53
1,023.84
1,228.78
1,339.02
944.39
1,393.96
Short Term Provisions
144.75
115.25
111.94
149.20
146.43
159.31
163.84
186.11
112.86
116.73
Total Liabilities
6,643.37
5,779.59
5,572.41
6,373.38
6,760.72
6,816.80
5,953.17
7,806.77
6,581.77
8,034.86
Net Block
2,100.35
1,888.12
1,853.18
2,298.42
2,333.45
2,151.13
2,025.85
3,570.13
2,903.00
2,909.03
Gross Block
3,303.39
2,897.25
2,873.18
3,324.82
3,231.69
2,841.28
2,534.38
4,049.05
3,229.03
3,186.12
Accumulated Depreciation
1,203.04
1,009.14
1,020.00
1,026.40
898.24
690.15
508.53
478.92
326.03
277.09
Non Current Assets
3,030.03
2,680.68
2,603.41
3,130.03
3,398.88
3,999.57
3,581.05
4,758.05
4,101.31
4,243.05
Capital Work in Progress
447.28
206.76
161.89
150.98
291.08
447.37
412.95
453.03
620.29
780.18
Non Current Investment
291.36
339.71
196.93
438.96
540.34
598.00
430.44
416.97
276.50
245.06
Long Term Loans & Adv.
163.66
140.19
256.13
217.18
210.58
187.83
214.69
227.76
206.54
222.69
Other Non Current Assets
27.14
94.73
123.38
11.91
10.26
547.00
424.33
12.78
21.40
15.48
Current Assets
3,612.79
3,098.91
2,969.00
3,135.25
3,361.83
2,817.23
2,370.61
3,048.72
2,446.53
3,791.82
Current Investments
0.00
69.50
105.76
50.84
0.00
99.41
118.97
284.75
311.48
1,279.54
Inventories
1,634.79
1,277.57
1,126.24
1,146.51
1,173.80
1,200.70
782.54
874.16
552.02
732.80
Sundry Debtors
1,288.96
1,202.94
1,141.87
1,299.40
1,207.30
1,110.59
931.69
987.18
882.18
995.91
Cash & Bank
213.14
136.78
191.17
315.96
187.35
179.76
237.10
516.65
303.33
329.48
Other Current Assets
475.89
276.20
228.99
169.21
793.39
226.76
300.31
385.98
397.52
454.10
Short Term Loans & Adv.
154.85
135.92
174.97
153.34
145.49
128.54
218.24
249.11
311.71
245.26
Net Current Assets
717.30
507.39
89.74
145.05
-49.84
78.89
-174.25
386.48
550.36
687.95
Total Assets
6,642.82
5,779.59
5,572.41
6,265.28
6,760.71
6,816.80
5,951.66
7,806.77
6,547.84
8,034.87

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
702.52
684.37
701.07
44.41
-257.81
481.44
204.79
60.05
187.07
288.14
PBT
668.69
3,675.03
-62.72
-267.63
-652.51
289.38
48.51
344.37
705.80
497.14
Adjustment
205.39
-2,884.12
818.27
682.19
582.27
363.31
527.49
94.59
-274.51
190.92
Changes in Working Capital
-100.45
-173.58
-78.73
-457.80
-189.90
-328.05
-326.23
-323.14
-190.66
-341.30
Cash after chg. in Working capital
773.63
617.34
676.82
-43.23
-260.14
324.64
249.76
115.82
240.63
346.76
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-71.11
67.04
24.25
87.64
2.33
156.80
-44.98
-55.76
-53.56
-58.62
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-173.04
-89.69
-150.25
302.47
-118.73
-520.82
1,306.16
-148.49
582.59
-686.69
Net Fixed Assets
-175.27
-32.00
-315.30
-54.00
-61.59
-86.75
-167.06
-48.49
677.20
-236.66
Net Investments
-20.59
515.90
128.18
-92.01
-5.11
-224.10
-21.67
-372.21
743.57
-147.22
Others
22.82
-573.59
36.87
448.48
-52.03
-209.97
1,494.89
272.21
-838.18
-302.81
Cash from Financing Activity
-453.41
-642.58
-693.32
-213.92
421.32
-15.80
-1,709.45
194.27
-1,015.69
338.21
Net Cash Inflow / Outflow
76.07
-47.90
-142.51
132.96
44.77
-55.18
-198.50
105.83
-246.03
-60.33
Opening Cash & Equivalents
112.56
161.02
303.50
170.73
125.83
182.23
365.89
256.16
515.08
1,110.74
Closing Cash & Equivalent
188.70
112.56
161.02
303.50
170.73
125.83
182.23
365.89
256.16
515.08

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
337.08
276.83
230.95
242.83
262.48
309.09
281.55
294.94
274.26
306.41
ROA
9.25%
7.21%
-2.41%
-3.52%
-6.99%
5.35%
2.00%
5.22%
9.59%
5.79%
ROE
20.31%
17.52%
-6.67%
-10.15%
-18.49%
12.91%
5.34%
14.74%
27.00%
16.53%
ROCE
18.57%
16.56%
3.47%
-0.49%
-9.49%
11.17%
6.01%
8.65%
16.07%
10.75%
Fixed Asset Turnover
2.28
2.46
1.96
1.91
1.75
2.04
1.50
1.17
1.04
1.27
Receivable days
64.34
60.35
73.17
73.25
79.41
68.09
70.88
79.95
102.49
96.77
Inventory Days
75.20
61.86
68.12
67.80
81.35
66.13
61.20
61.00
70.11
64.20
Payable days
218.23
173.66
191.36
230.40
267.95
264.54
138.58
146.59
116.23
117.33
Cash Conversion Cycle
-78.69
-51.45
-50.07
-89.35
-107.20
-130.32
-6.50
-5.64
56.37
43.64
Total Debt/Equity
0.54
0.70
1.14
1.27
1.18
0.76
0.78
1.22
1.03
1.35
Interest Cover
4.75
2.96
0.59
-0.10
-2.69
3.49
2.00
5.92
4.68
3.71

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • USFDA concludes cGMP inspection at formulations facility of Strides Pharma Science
    12th Sep 2026, 11:02 AM

    At the conclusion of the inspection, the USFDA has issued a Form 483 with three observations

    Read More
  • Strides Pharma secures EIR from USFDA for manufacturing facility in Bengaluru
    20th Aug 2026, 14:42 PM

    The USFDA has classified the inspection outcome as Voluntary Action Indicated

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.